Key result
Bisoprolol offers effective, metabolically neutral blood pressure control for high-risk worksite hypertension.
Why the study?
Stress is a significant risk factor for arterial hypertension, with worksite hypertension being a prevalent variant linked to increased cardiovascular risk, but detailed mechanisms and treatment options require synthesis.
Worksite hypertension is a prevalent form of stress-induced hypertension associated with increased cardiovascular risk, where highly selective beta-blockers like bisoprolol may offer targeted pathogenetic benefits.
Stress may elevate hypertension risk via sympathetic activation; leaves open targeted intervention trials.
The review presents a modern view on stress as a risk factor for the development of arterial hypertension (AH). A variety pathogenic mechanisms responsible for increase of blood pressure during stress exposure are described in detail. The importance of the sympathetic activation as a key link in the development of stress-induced AH and initiation of a cascade of pathophysiological reactions that realize their adverse effects at the level of the whole organism is underlined. Particular attention is paid to worksite AH as a variant of stress-induced hypertension due to its wide prevalence and association with an increased risk of cardiovascular complications, primarily myocardial infarction and stroke. Epidemiological data and results of recent metanalysis are presented, indicating the high significance of job strain as a risk factor for adverse cardiovascular events. The actual psychological stress reduction programs are described. Possibilities of using β-blockers in patients with stress-induced hypertension as drugs affecting the central pathogenetic trigger of this disease are considered. The advantages of using bisoprolol as a highly selective β-blocker are considered taking into account the available body of evidence for its effectiveness in patients with worksite AH, as well as its metabolic neutrality and target-organ protective properties.
No takes yet. Share an insight, caveat, or question.
Ostroumova et al. (2018) conducted a review in Worksite hypertension. Bisoprolol was evaluated. Worksite hypertension is a prevalent variant of stress-induced hypertension that increases cardiovascular risk, and highly selective beta-blockers like bisoprolol provide effective and metabolically neutral treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: